within Pharmacolibrary.Drugs.L_AntineoplasticAndImmunomodulatingAgents.L02A_HormonesAndRelatedAgents.L02AE05_Histrelin;
model Histrelin 
   extends Pharmacolibrary.Drugs.ATC.L.L02AE05;

  annotation(Documentation(
    info ="<html><body><p>Histrelin is a potent gonadotropin-releasing hormone (GnRH) agonist used primarily in the treatment of hormone-sensitive conditions such as central precocious puberty in children and advanced prostate cancer in adults. It is typically delivered as a subcutaneous implant for sustained drug release and is approved for these indications.</p><h4>Pharmacokinetics</h4><p>Pharmacokinetic parameters derived in adult healthy male subjects after a single intravenous infusion of histrelin.</p><h4>References</h4><ol></ol></body></html>",
    revisions = "<html><body><ul><li>06/2025 model generated by LLM gpt-4.1, references by scholarly and scripts created by Tomas Kulhanek</li></ul></body></html>",
    experiment(StartTime = 0, StopTime = 86400, Tolerance = 1e-09, Interval = 1)
  ));  
end Histrelin;
